Best Practices

In an open-label study to investigate the safety of combining biologic agents in the treatment of rheumatoid arthritis, researchers found little serious risk when rituximab (Rituxan) was added to other drugs.

First biologic agent approved for the treatment of moderately to severely active ulcerative colitis in children.

Risk of acute kidney injury increased within one year of starting the antiobesity drug orlistat, study finds.

Review of herbal menopause treatments.

Review finds little evidence to support benefit for most medical treatments in children with autism spectrum disorders.

Drug indicated for use in combination with prednisone or prednisolone.

The federal government is supporting the development of a new cancer radiation therapy device that could lead to more precise and life-saving treatment methods.